Publicaciones - Patología Molecular y Farmacogenética

Cargando...

Lazaro Sanchez AD, Benitez Fuentes JD, Gil GL, Garcia MTG, Moreno EF, Zamora PC, Yago JB, Mohamed KM, Arroyo Rodriguez AB. Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report. J Clin Med. 2025 Feb 17;14(4):1333. doi: 10.3390/jcm14041333. PubMed PMID: 40004863; PubMed Central PMCID: PMC11856639.

AÑO: 2025; IF: 2.9

40004863

Feliciangeli E, Albaladejo-Gonzalez A, Garcia-Rodriguez J, Lazaro-Sanchez A, Borg R, Pimentel-Caceres P, Soriano-Polo D, Rodriguez-Braun E, Balsalobre-Yago J, Martinez-Ortiz MJ, Wikstrom-Fernandez S, Murillo-Herrera A, Garcia-Garcia T, Garcia-Solano J, Conesa-Zamora P, Luengo-Gil G. Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Sci Rep. 2025 Jul 1;15(1):21626. doi: 10.1038/s41598-025-04962-w. PubMed PMID: 40594059.

AÑO: 2025; IF: 3.9

40594059

Perez-Parra D, Postigo-Corrales F, Cruz Santos AF, Sanchez-Espinosa A, Acosta-Ortega J, Carrillo-Vicente R, Lopez-Abellan MD, Conesa-Zamora P, Luengo-Gil G, Hurtado-Lopez AM. Characterization and Prognostic Impact of Fascin Expression in the Tumor Microenvironment of Triple-Negative Breast Cancer: Clues for a Tailored Therapy. Lab Invest. 2025 Nov 28:104268. doi: 10.1016/j.labinv.2025.104268. Online ahead of print. PubMed PMID: 41319754.

AÑO: 2025; IF: 4.2

41319754

Ruiz-Artacho P., Lecumberri R., Trujillo-Santos J., Beddar Chaib F., Moustafa F., Lorenzo A., Gómez-Cuervo C., Bosevski M., Monreal M. Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence. Thrombosis and Haemostasis. 2025. 10.1055/a-2615-4513

AÑO: 2025; IF: 4.3

40389231

Sanchez-Espinosa A, Garcia-Rodriguez J, Alonso-Aguirre V, Acosta-Ortega JM, Conesa-Zamora P, Garcia-Solano J, Luengo-Gil G. Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers. Int J Mol Sci. 2025 Mar 27;26(7):3076. doi: 10.3390/ijms26073076. PubMed PMID: 40243780; PubMed Central PMCID: PMC11988776.

AÑO: 2025; IF: 4.9

40243780

Siguiente >

Publicaciones - Patología Molecular y Farmacogenética

Instituto de Investigación Sanitaria Acreditado

Patología Molecular y Farmacogenética